Patients’ characteristics
The clinicopathological characteristics of the 1139 patients are shown in Table 1. There were 701 men, and the median age was 70.7 years. Median Brinkman Index was 600 and median BMI was 22.71. In total, 682 patients had comorbidities, including 28 patients with atrial fibrillation, 91 with angina pectoris, 41 with ILD, 399 with COPD, 38 with asthma, and 169 with diabetes mellitus. Median CEA concentration was 3.4 ng/ml, median PNI was 49.8, NLR was 2.22, and median CIPI was 7.92. The pulmonary lobes resected for NSCLC included the right upper lobe in 344 patients, right middle lobe in 69, right lower lobe in 271, left upper lobe in 267, and left lower lobe in 188.
Table 1
Variables | Values |
Gender (male / female) | 701 / 438 |
Age, median (range) (y) | 70.7 (22–92) |
Brinkman index, median (range) | 600 (0–3600) |
Body mass index, median (range) | 22.71 (13.54–41.06) |
Comorbidity, present (%) | 682 (60%) |
Charlson comorbidity index (0 / 1 / 2 / 3 / 4 / 5 / 6 / 7 / 8) | 604 / 277 / 192 / 46 / 14 / 3 / 2 / 1 |
Atrial fibrillation, present (%) | 28 (2.5%) |
Angina pectoris, present (%) | 91 (8.0%) |
Interstitial lung disease, present (%) | 41 (3.6%) |
Chronic obstructive pulmonary disease, present (%) | 399 (35.0%) |
Asthma, present (%) | 38 (3.3%) |
Diabetes mellitus, present (%) | 169 (14.8%) |
CEA, median (range) (ng/ml) | 3.4 (0.5–306.0) |
PNI, median (range) | 49.8 (26.95–67.59) |
NLR, median (range) | 2.22 (0.48–24.51) |
CIPI, median (range) | 7.92 (0.72–1465.74) |
Lobe of tumor (RU / RM / RL / LU / LL) | 344 / 69 / 271 / 267 / 188 |
Operative approach (RATS/ VATS/Open) | 62 / 398 / 679 |
Operative procedure (Wed/Seg/Lob/Sleeve Lob/Lob + Seg/Lob + CWR/Bilob/Pneumo) | 190 / 115 / 756 / 8 / 8 / 13 / 20 / 29 |
Operation time, median (range) (min) | 169 (26–1149) |
Histological type (Ad / Sq /LCNEC / AdSq / Pleo / Carci / Large) | 839 / 224 / 30 / 17 / 16 / 7 / 6 |
Lymphatic invasion, present (%) | 391 (34.3%) |
Vascular invasion, present (%) | 491 (43.1%) |
Differentiation (G1 / 2 / 3 / 4) | 366 / 570 / 168 / 35 |
Pathological stage (0 / IA / IB / IIA / IIB / IIIA/ IIIB / IV/ yIA / yIIA) | 64 / 605 / 202 / 46 / 112 / 94 / 4 / 3 / 8 / 1 |
Postoperative complications, present (%) | 327 (28.7%) |
Clavien-Dindo grade (0 / I / II / IIIa / IIIb / IV / V) | 812 / 2 / 129 / 183 / 12 / 0 / 1 |
Air leakage, present (%) | 141 (12.3%) |
Arrhythmia, present (%) | 64 (5.6%) |
Pneumonia, present (%) | 36 (3.1%) |
Atelectasis, present (%) | 32 (2.8%) |
Chylothorax, present (%) | 9 (0.8%) |
Home oxygen therapy, present (%) | 7 (0.6%) |
Cerebral infarction, present (%) | 6 (0.5%) |
Empyema or pleuritis, present (%) | 6 (0.5%) |
Surgical site infection, present (%) | 6 (0.5%) |
Broncho-pleural fistula, present (%) | 3 (0.3%) |
CEA; carcinoembryonic antigen, PNI; prognostic nutrition index, NLR; neutrophil-to-lymphocyte ratio, CIPI; cancer-inflammation prognostic index, RU; right upper, RM; right middle, RL; right lower, LU; left upper, LL; left lower, RATS; robotic assisted thoracic surgery, VATS; video assisted thoracic surgery, Open; open thoracotomy, Wed; wedge resection, Seg; segmentectomy, Lob; lobectomy, CWR; chest wall resection, Bilob; bi-lobectomy, Pneumo; pneumonectomy, Ad; adenocarcinoma, Sq; squamous cell carcinoma, LCNEC; large cell neuroendocrine carcinoma, AdSq; adenosquamous cell carcinoma, Pleo; pleomorphic carcinoma, Carci; carcinoid, Large; large cell carcinoma, G; grade of differentiation, y; yield to treatment. |
Surgical factors
RATS was performed in 62 patients, VATS in 398, and open thoracotomy in 679. With regards to the surgical procedures, wedge resection was performed in 190 patients, segmentectomy in 115, lobectomy in 756, sleeve lobectomy in 8, lobectomy combined with segmentectomy in 8, lobectomy with chest wall resection in 13, bilobectomy in 20, and pneumonectomy in 29. The median surgery time was 169 minutes.
Pathological factors
The histological types were as follows: adenocarcinoma in 839 patients, squamous cell carcinoma in 224, large cell neuroendocrine carcinoma in 30, adenosquamous cell carcinoma in 17, pleomorphic carcinoma in 16, carcinoid in 7, and large-cell carcinoma in 6. Lymphatic invasion was present in 391 patients and vascular invasion in 491. Differentiation was categorized as G1 in 36 patients, G2 in 570, G3 in 168, and G4 in 35. The pathological stages were: stage 0 in 64 patients, IA in 605, IB in 202, IIA in 46, IIB in 112, IIIA in 94, IIIB in 4, IV in 8, yield to treatment (y) IA in 8, and yIIA in 1.
Postoperative complications
Postoperative complications were observed in 327 patients (28.7%). Clavien–Dindo grade I complications were noted in 2 patients, grade II in 129, grade IIIa in 183, grade IIIb in 12, and grade V in 1. Major postoperative complications included air leakage in 141 patients, arrhythmia in 64, pneumonia in 36, and atelectasis in 32. Minor postoperative complications were chylothorax in nine patients, home oxygen therapy in seven, cerebral infarction in six, empyema or pleuritis in six, surgical site infection in six, and broncho-pleural fistula in three.
Cutoff values calculated from ROC curves
The cutoff values of factors associated with postoperative complications were calculated by ROC curve analysis. The following cutoff values were determined: age, 65 years; BMI, 21.68; PNI, 45.52; CIPI, 7.25; CIPI, 14.59; and surgery time, 155 minutes.
Univariate and multivariate analyses
The relationship between patient characteristics and postoperative complications was analyzed (Table 2). The following were significant factors for postoperative complications in the univariate analysis: male sex (P < 0.01), age ≥ 65 years (P < 0.01), Brinkman index ≥ 600 (P < 0.01), coexistence of COPD (P < 0.01), PNI < 45.52 (P < 0.01), CIPI > 7.25 (P = 0.01), upper lobe (P < 0.01), lobectomy or extended resection more than lobectomy (P < 0.01), surgery time ≥ 155 minutes (P < 0.01), non-adenocarcinoma (P < 0.01), presence of lymphatic invasion (P < 0.01), presence of vascular invasion (P = 0.02), and presence of grade 3/4 differentiation (P < 0.01). Male sex (P = 0.01), age ≥ 65 years (P < 0.01), coexistence of COPD (P < 0.01), upper lobe (P < 0.01), surgery time ≥ 155 minutes (P < 0.01), and presence of lymphatic invasion (P = 0.01) were significant factors for postoperative complication in the multivariate analysis. The relationship between patient characteristics and severe postoperative complication was analyzed (Table 3). The following were significant factors for severe postoperative complication in the univariate analysis: male sex (P < 0.01), age ≥ 65 years (P = 0.04), Brinkman index ≥ 600 (P < 0.01), BMI < 21.68 (P < 0.01), coexistence of COPD (P < 0.01), CIPI > 7.25 (P < 0.01), lobectomy or extended resection more than lobectomy (P = 0.01), surgery time ≥ 155 minutes (P < 0.01), non-adenocarcinoma (P = 0.02), presence of lymphatic invasion (P = 0.01), and presence of grade 3/4 differentiation (P = 0.01). Male sex (P < 0.01), age ≥ 65 years (P = 0.02), BMI < 21.68 (P < 0.01), coexistence of COPD (P = 0.02), and surgery time ≥ 155 minutes (P = 0.01) were significant factors for severe postoperative complication in the multivariate analysis.
Table 2
Univariate analysis and multivariate analysis of risk factor for postoperative complication
Univariate analysis | | Multivariate analysis |
Variables | | Odds ratio | 95% CI | P value | | Odds ratio | 95% CI | P value |
Gender | male | 2.23 | 1.682–2.970 | < 0.01 | | 1.58 | 1.083–2.312 | 0.01 |
Age | ≥ 65 | 1.59 | 1.175–2.176 | < 0.01 | | 1.59 | 1.145–2.231 | < 0.01 |
Smoking status | BI ≥ 600 | 1.94 | 1.496–2.530 | < 0.01 | | 0.99 | 0.681–1.442 | 0.96 |
BMI | < 21.68 | 1.26 | 0.974–1.654 | 0.07 | | | | |
Charlson comorbidity index | ≥ 3 | 0.65 | 0.357–1.196 | 0.16 | | | | |
Atrial fibrillation | present | 0.67 | 0.269–1.670 | 0.39 | | | | |
Angina pectoris | present | 1.31 | 0.833–2.066 | 0.24 | | | | |
Interstitial lung disease | present | 0.79 | 0.385–1.640 | 0.53 | | | | |
COPD | present | 2.02 | 1.554–2.633 | < 0.01 | | 1.57 | 1.177–2.106 | < 0.01 |
Asthma | present | 1.84 | 0.957–3.564 | 0.06 | | | | |
Diabetes mellitus | present | 0.949 | 0.659–1.366 | 0.77 | | | | |
PNI | < 45.52 | 1.52 | 1.123–2.072 | < 0.01 | | 1.27 | 0.922–1.773 | 0.14 |
CIPI | > 7.25 | 1.40 | 1.084–1.826 | 0.01 | | 1.11 | 0.844–1.485 | 0.43 |
Location of lesion | Upper lobe | 1.50 | 1.162–1.960 | < 0.01 | | 1.49 | 1.134–1.970 | < 0.01 |
Operative approach | Thoracoscopic surgery | 1.01 | 0.782–1.320 | 0.90 | | | | |
Operative procedure | Lobe or extend | 1.77 | 1.300-2.433 | < 0.01 | | 1.34 | 0.931–1.951 | 0.11 |
Operation time | ≥ 155min | 2.04 | 1.558–2.688 | < 0.01 | | 1.76 | 1.281–2.423 | < 0.01 |
Histological type | Non-adenocarcinoma | 1.76 | 1.333–2.336 | < 0.01 | | 1.23 | 0.886–1.707 | 0.21 |
Lymphatic invasion | present | 1.61 | 1.237–2.102 | < 0.01 | | 1.51 | 1.077–2.130 | 0.01 |
Vascular invasion | present | 1.34 | 1.038–1.740 | 0.02 | | 0.81 | 0.580–1.152 | 0.25 |
Differentiation | G3-4 | 1.76 | 1.286–2.427 | < 0.01 | | 1.35 | 0.942–1.942 | 0.10 |
Pathological stage | ≥ II | 1.15 | 0.855–1.553 | 0.34 | | | | |
CI; confidence interval, BI; Brinkman index, BMI; body mass index, COPD; chronic obstructive pulmonary disease, PNI; prognostic nutrition index, CIPI; cancer-inflammation prognostic index, Lobe or extend; lobectomy or extend resection more than lobectomy, G; grade of differentiation. |
Table 3
Univariate analysis and multivariate analysis of risk factor for postoperative severe complication
Univariate analysis | | Multivariate analysis |
Variables | | Odds ratio | 95% CI | P value | | Odds ratio | 95% CI | P value |
Gender | male | 2.24 | 1.578–3.194 | < 0.01 | | 2.03 | 1.286–3.233 | < 0.01 |
Age | ≥ 65 | 1.46 | 1.007–2.122 | 0.04 | | 1.55 | 1.048–2.321 | 0.02 |
Smoking status | BI ≥ 600 | 1.74 | 1.273–2.391 | < 0.01 | | 0.87 | 0.561–1.352 | 0.53 |
BMI | < 21.68 | 1.91 | 1.402–2.612 | < 0.01 | | 2.13 | 1.541–2.952 | < 0.01 |
Charlson comorbidity index | ≥ 3 | 0.74 | 0.363–1.537 | 0.42 | | | | |
Atrial fibrillation | present | 0.79 | 0.273–2.325 | 0.67 | | | | |
Angina pectoris | present | 1.11 | 0.642–1.935 | 0.69 | | | | |
Interstitial lung disease | present | 0.51 | 0.179–1.448 | 0.20 | | | | |
COPD | present | 1.78 | 1.307–2.440 | < 0.01 | | 1.47 | 1.051–2.079 | 0.02 |
Asthma | present | 2.01 | 0.983–4.138 | 0.05 | | | | |
Diabetes mellitus | present | 1.09 | 0.717–1.674 | 0.67 | | | | |
PNI | < 45.52 | 1.30 | 0.902–1.874 | 0.15 | | | | |
CIPI | > 7.25 | 1.52 | 1.111–2.092 | < 0.01 | | 1.19 | 0.853–1.675 | 0.29 |
Location of lesion | Upper lobe | 1.24 | 0.913–1.703 | 0.16 | | | | |
Operative approach | Thoracoscopic surgery | 1.07 | 0.786–1.469 | 0.64 | | | | |
Operative procedure | Lobe or extend | 1.58 | 1.083–2.308 | 0.01 | | 1.35 | 0.871–2.115 | 0.17 |
Operation time | ≥ 155min | 1.80 | 1.301–2.511 | < 0.01 | | 1.58 | 1.078–2.316 | 0.01 |
Histological type | Non-adenocarcinoma | 1.45 | 1.041–2.026 | 0.02 | | 0.99 | 0.680–1.457 | 0.98 |
Lymphatic invasion | present | 1.47 | 1.077–2.021 | 0.01 | | 1.23 | 0.871–1.739 | 0.23 |
Vascular invasion | present | 1.23 | 0.908–1.683 | 0.17 | | | | |
Differentiation | G3-4 | 1.59 | 1.099–2.304 | 0.01 | | 1.25 | 0.832–1.880 | 0.28 |
Pathological stage | ≥ II | 0.96 | 0.667–1.386 | 0.83 | | | | |
CI; confidence interval, BI; Brinkman index, BMI; body mass index, COPD; chronic obstructive pulmonary disease, PNI; prognostic nutrition index, CIPI; cancer-inflammation prognostic index, Lobe or extend; lobectomy or extend resection more than lobectomy, G; grade of differentiation. |
Risk factors of each postoperative complication
The significant risk factors of each postoperative complication by multivariate analysis are shown in Table 4. Male sex (P < 0.01), age ≥ 65 years (P = 0.03), Brinkman index ≥ 600 (P = 0.02), BMI < 21.68 (P < 0.01), coexistence of COPD (P < 0.01), CIPI > 7.25 (P = 0.01), thoracoscopic surgery (P = 0.01), and surgery time ≥ 155 minutes (P = 0.04) were significant risk factors for postoperative air leakage in the univariate analysis (data not shown). However, male sex (P = 0.01), BMI < 21.68 (P < 0.01), thoracoscopic surgery (P < 0.01), and surgery time ≥ 155 minutes (P < 0.01) were significant risk factors for postoperative air leakage in the multivariate analysis.
Table 4
Multivariate analysis of risk factors for each postoperative complication
Postoperative complication | Risk factors | | Odds ratio | 95%CI | P value |
Air leakage | Gender | Male | 1.93 | 1.156–3.242 | 0.01 |
| Age | ≥ 65 | 1.56 | 0.988–2.437 | 0.05 |
| Smoking status | BI ≥ 600 | 0.82 | 0.514–1.327 | 0.43 |
| BMI | < 21.68 | 2.31 | 1.605–3.347 | < 0.01 |
| COPD | Present | 1.45 | 0.988–2.141 | 0.05 |
| CIPI | > 7.25 | 1.29 | 0.880–1.900 | 0.18 |
| Operative approach | Thoracoscopic surgery | 1.80 | 1.236–2.621 | < 0.01 |
| Operation time | ≥ 155min | 1.72 | 1.162–2.563 | < 0.01 |
Arrhythmia | PNI | < 45.52 | 2.17 | 1.252–3.761 | < 0.01 |
| Operative approach | Thoracoscopic surgery | 0.77 | 0.422–1.415 | 0.40 |
| Operative procedure | Lobe or extend | 5.99 | 1.381–26.021 | 0.01 |
| Operation time | ≥ 155min | 3.10 | 1.413–6.815 | < 0.01 |
| Histological type | Non-adenocarcinoma | 1.55 | 0.900-2.698 | 0.11 |
| Lymphatic invasion | Present | 1.08 | 0.580–2.026 | 0.79 |
| Vascular invasion | Present | 1.31 | 0.693-2.500 | 0.40 |
| Differentiation | G3-4 | 1.35 | 0.719–2.541 | 0.34 |
| Pathological stage | ≥ II | 0.88 | 0.495–1.579 | 0.67 |
Atelectasis | COPD | Present | 2.46 | 1.189–5.093 | 0.01 |
| Asthma | Present | 5.15 | 1.822–14.564 | < 0.01 |
| Location of lesion | Upper lobe | 2.10 | 0.959–4.638 | 0.06 |
Pneumonia | Gender | Male | 1.23 | 0.398–3.832 | 0.71 |
| Smoking status | BI ≥ 600 | 2.88 | 0.960–8.856 | 0.05 |
| COPD | Present | 1.85 | 0.918–3.757 | 0.08 |
| Histological type | Non-adenocarcinoma | 1.16 | 0.566–2.402 | 0.67 |
Chylothorax | Not significant | | | | |
Home oxygen therapy | Not significant | | | | |
Cerebral infarction | Not significant | | | | |
Empyema or pleuritis | Not significant | | | | |
Surgical site infection | Not significant | | | | |
CI; confidence interval, BI; Brinkman index, BMI; body mass index, COPD; chronic obstructive pulmonary disease, CIPI; cancer-inflammation prognostic index, PNI; prognostic nutrition index, Lobe or extend; lobectomy or extend resection more than lobectomy, G; grade of differentiation. |
PNI < 45.52 (P < 0.01), thoracoscopic surgery (P = 0.01), lobectomy or extended resection more than lobectomy (P < 0.01), surgery time ≥ 155 minutes (P < 0.01), non-adenocarcinoma (P < 0.01), presence of lymphatic invasion (P = 0.03), presence of vascular invasion (P = 0.01), presence of grade 3/4 differentiation (P = 0.02), and pathological stage ≥ II (P = 0.03) were significant factors for postoperative arrhythmia in the univariate analysis (data not shown). In the multivariate analysis, PNI < 45.52 (P < 0.01), lobectomy or extended resection more than lobectomy (P = 0.01), and surgery time ≥ 155 minutes (P < 0.01) were significant risk factors for postoperative arrhythmia.
Coexistence of COPD (P < 0.01), coexistence of asthma (P < 0.01), and upper lobe (P = 0.04) were significant factors for postoperative atelectasis in the univariate analysis (data not shown). However, coexistence of COPD (P = 0.01) and coexistence of asthma (P < 0.01) were the only significant risk factors for postoperative atelectasis in the multivariate analysis.
While male sex (P < 0.01), Brinkman index ≥ 600 (P < 0.01), coexistence of COPD (P < 0.01), and non-adenocarcinoma (P = 0.03) were significant factors for postoperative pneumonia in the univariate analysis (data not shown), there were no significant risk factors for postoperative pneumonia in the multivariate analysis.
Although we analyzed the risk factors of chylothorax, home oxygen therapy, cerebral infarction, empyema or pleuritis and surgical site infection, significant risk factors could not be identified.